Buscar
Sanara Medtech Inc
SMTIAñadir a la lista de seguimiento
33.860USD
-0.200-0.59%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
311.28MCap. mercado
PérdidaP/E TTM
Más Datos de Sanara Medtech Inc Compañía
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
Información de Sanara Medtech Inc
Símbolo de cotizaciónSMTI
Nombre de la empresaSanara Medtech Inc
Fecha de salida a bolsaApr 07, 1994
Director ejecutivoMuppalla (Suresh V)
Número de empleados141
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 07
Dirección1200 Summit Avenue
CiudadFORT WORTH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal76102
Teléfono18175292300
Sitio Webhttps://sanaramedtech.com/
Símbolo de cotizaciónSMTI
Fecha de salida a bolsaApr 07, 1994
Director ejecutivoMuppalla (Suresh V)
Ejecutivos de Sanara Medtech Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
9.32K
+47.02%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Robert A. (Bob) DeSutter
Mr. Robert A. (Bob) DeSutter
Independent Director
Independent Director
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Sanara Medtech Inc?
Los cinco principales accionistas de Sanara Medtech Inc son: Mr. Seth D. Yon
¿Cuántas instituciones poseen acciones de Sanara Medtech Inc (SMTI)?
A fecha de 2026Q1, 131 instituciones poseen acciones de Sanara Medtech Inc, con un valor de mercado combinado de aproximadamente 1.42M, lo que representa el 15.50% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -599767.00.
¿Cuál es la mayor fuente de ganancias de Sanara Medtech Inc?
El 2026Q1, el segmento empresarial Soft tissue repair products generó la ganancia más alta para Sanara Medtech Inc, ascendiendo a 91.35M y representando el 88.59% de la ganancia total.